MedPath

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Phase 3
Conditions
Breast Cancer
Registration Number
NCT00002460
Lead Sponsor
Cancer Research UK
Brief Summary

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by blocking the uptake of estrogen.

PURPOSE: Phase III trial to compare the effectiveness of adjuvant therapy using tamoxifen or ovarian ablation with goserelin or both in treating women with stage I or stage II breast cancer.

Detailed Description

OBJECTIVES: I. Determine, in a prospective, randomized, controlled trial whether the administration of a course of adjuvant tamoxifen or ablation of ovarian function results in prolongation of time to recurrence or death in patients under 50 years of age with operable carcinoma of the breast. II. Determine how hormone manipulation affects mood and sexual functioning in these patients.

OUTLINE: This is a randomized study. Patients are stratified by clinician. All patients are randomized following primary therapy, which, in addition to surgery, may include local irradiation, perioperative cyclophosphamide, or up to 6 cycles of cyclophosphamide, methotrexate, and fluorouracil (CMF) for high-risk patients. Clinicians may elect to randomize patients to all groups or to only those groups including tamoxifen. The first group receives no further therapy. Then second group receives tamoxifen daily for at least 2 years. The third group receives ovarian ablation with goserelin via monthly injection for at least 2 years. The final group receives ovarian ablation with goserelin plus daily tamoxifen for at least 2 years. All patients are followed every 3 months for 2 years, every 6 months for 3 years, then annually.

PROJECTED ACCRUAL: 800 to 1,000 patients will be entered.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (33)

Clatterbridge Centre for Oncology NHS Trust

🇬🇧

Merseyside, England, United Kingdom

Institut Jules Bordet

🇧🇪

Brussels, Belgium

Royal Marsden NHS Trust

🇬🇧

London, England, United Kingdom

U.Z. Sint-Rafael

🇧🇪

Leuven, Belgium

Walsgrave Hospital

🇬🇧

Coventry, England, United Kingdom

Cookridge Hospital

🇬🇧

Leeds, England, United Kingdom

Middlesex Hospital- Meyerstein Institute

🇬🇧

London, England, United Kingdom

South Tees Acute Hospitals NHS Trust

🇬🇧

Middlesbrough, Cleveland, England, United Kingdom

Royal Marsden Hospital

🇬🇧

Sutton, England, United Kingdom

Royal Hampshire County Hospital

🇬🇧

Winchester, England, United Kingdom

Sunderland Royal Infirmary

🇬🇧

Sunderland, England, United Kingdom

Portsmouth Hospitals NHS Trust

🇬🇧

Portsmouth, England, United Kingdom

Salisbury General Infirmary

🇬🇧

Salisbury, England, United Kingdom

North Tees General Hospital

🇬🇧

Stockton-On-Tees, England, United Kingdom

Ards General Hospital

🇬🇧

Newtownards, Northern Ireland, United Kingdom

Ninewells Hospital and Medical School

🇬🇧

Dundee, Scotland, United Kingdom

Radiotherapy Department

🇬🇧

Stratford-on-Avon, Warwickshire, England, United Kingdom

Mayday University Hospital

🇬🇧

Croydon, England, United Kingdom

Hopital De Braine-L'Alleud-Waterloo

🇧🇪

Braine-L'Alleud, Belgium

Southampton General Hospital

🇬🇧

Southampton, England, United Kingdom

Belfast City Hospital Trust

🇬🇧

Belfast, Northern Ireland, United Kingdom

Mid-Ulster Hospital

🇬🇧

Londonderry, Northern Ireland, United Kingdom

Cancer Research Campaign Clinical Trials Unit-London

🇬🇧

London, England, United Kingdom

Derriford Hospital

🇬🇧

Plymouth, England, United Kingdom

Royal Sussex County Hospital

🇬🇧

Brighton, England, United Kingdom

Huddersfield Royal Infirmary

🇬🇧

Huddersfield, West Yorks, England, United Kingdom

North Staffs Royal Infirmary

🇬🇧

Stoke-On-Trent, England, United Kingdom

Velindre Hospital

🇬🇧

Cardiff, Wales, United Kingdom

Guy's, King's and St. Thomas' Hospitals Trust

🇬🇧

London, England, United Kingdom

Newcastle General Hospital

🇬🇧

Newcastle Upon Tyne, England, United Kingdom

Whittington Hospital

🇬🇧

London, England, United Kingdom

Royal South Hants Hospital

🇬🇧

Southampton, England, United Kingdom

Castle Hill Hospital

🇬🇧

Cottingham, England, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath